BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36004775)

  • 1. Transformable ECM Deprivation System Effectively Suppresses Renal Cell Carcinoma by Reversing Anoikis Resistance and Increasing Chemotherapy Sensitivity.
    Wang L; Li C; Wang J; Yang G; Lv Y; Fu B; Jian L; Ma J; Yu J; Yang Z; Wu P; Li G; Liu X; Kang Z; Wang Z; Wang L; Wang H; Xu W
    Adv Mater; 2022 Oct; 34(43):e2203518. PubMed ID: 36004775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAK-independent alphavbeta3 integrin-EGFR complexes rescue from anoikis matrix-defective fibroblasts.
    Zoppi N; Barlati S; Colombi M
    Biochim Biophys Acta; 2008 Jun; 1783(6):1177-88. PubMed ID: 18405669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase.
    Zhang Y; Lu H; Dazin P; Kapila Y
    J Biol Chem; 2004 Nov; 279(46):48342-9. PubMed ID: 15331608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.
    Nakagawa Y; Nakayama H; Nagata M; Yoshida R; Kawahara K; Hirosue A; Tanaka T; Yuno A; Matsuoka Y; Kojima T; Yoshitake Y; Hiraki A; Shinohara M
    Int J Oncol; 2014 Apr; 44(4):1376-84. PubMed ID: 24452447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts.
    Zoppi N; Ritelli M; Colombi M
    Biochim Biophys Acta; 2012 Oct; 1820(10):1576-87. PubMed ID: 22705941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin regulates anoikis resistance via cell aggregate formation.
    Han HJ; Sung JY; Kim SH; Yun UJ; Kim H; Jang EJ; Yoo HE; Hong EK; Goh SH; Moon A; Lee JS; Ye SK; Shim J; Kim YN
    Cancer Lett; 2021 Jun; 508():59-72. PubMed ID: 33771684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKM2 allosteric converter: A self-assembly peptide for suppressing renal cell carcinoma and sensitizing chemotherapy.
    Wang L; Fu B; Hou DY; Lv YL; Yang G; Li C; Shen JC; Kong B; Zheng LB; Qiu Y; Wang HL; Liu C; Zhang JJ; Bai SY; Li LL; Wang H; Xu WH
    Biomaterials; 2023 May; 296():122060. PubMed ID: 36934477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
    Kamarajan P; Kapila YL
    Apoptosis; 2007 Dec; 12(12):2221-31. PubMed ID: 17879163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing Focal Adhesions to Accelerate p53 Accumulation and Anoikis of A549 Cells Using Colloidal Self-Assembled Patterns (cSAPs).
    Enkhbat M; Zhong B; Chang R; Geng J; Lu LS; Chen YJ; Wang PY
    ACS Appl Bio Mater; 2022 Jan; 5(1):322-333. PubMed ID: 35034455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiadhesive sites present in the fibronectin type III-like repeats of human plasma fibronectin.
    Miura S; Kamiya S; Saito Y; Wada S; Hayashi R; Taira J; Kodama H; Yajima H; Ueki M; Fukai F
    Biol Pharm Bull; 2007 May; 30(5):891-7. PubMed ID: 17473431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting anoikis resistance in prostate cancer metastasis.
    Sakamoto S; Kyprianou N
    Mol Aspects Med; 2010 Apr; 31(2):205-14. PubMed ID: 20153362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.
    Malin D; Strekalova E; Petrovic V; Rajanala H; Sharma B; Ugolkov A; Gradishar WJ; Cryns VL
    Oncogene; 2015 Nov; 34(45):5626-34. PubMed ID: 25684139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer.
    Dong B; Gu Y; Sun X; Wang X; Zhou Y; Rong Z; Zhang J; Shi X; Zhang Z; He X; Chen L; Xiong Q; Pang X; Cui Y
    Adv Healthc Mater; 2024 May; ():e2400673. PubMed ID: 38809199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIFα independent mechanisms in renal carcinoma cells modulate divergent outcomes in fibronectin assembly mediated by hypoxia and CoCl
    Magdaleno C; Dixon L; Rajasekaran N; Varadaraj A
    Sci Rep; 2020 Oct; 10(1):18560. PubMed ID: 33122751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma.
    Sakamoto S; Schwarze S; Kyprianou N
    Eur Urol; 2011 May; 59(5):734-44. PubMed ID: 21269758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference with Tim-3 protein expression attenuates the invasion of clear cell renal cell carcinoma and aggravates anoikis.
    Yu M; Lu B; Liu Y; Me Y; Wang L; Li H
    Mol Med Rep; 2017 Mar; 15(3):1103-1108. PubMed ID: 28112366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents.
    Díaz-Montero CM; McIntyre BW
    BMC Cancer; 2005 Apr; 5():39. PubMed ID: 15829011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR).
    Hazlehurst LA; Damiano JS; Buyuksal I; Pledger WJ; Dalton WS
    Oncogene; 2000 Sep; 19(38):4319-27. PubMed ID: 10980607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.
    Oudin MJ; Jonas O; Kosciuk T; Broye LC; Guido BC; Wyckoff J; Riquelme D; Lamar JM; Asokan SB; Whittaker C; Ma D; Langer R; Cima MJ; Wisinski KB; Hynes RO; Lauffenburger DA; Keely PJ; Bear JE; Gertler FB
    Cancer Discov; 2016 May; 6(5):516-31. PubMed ID: 26811325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
    Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
    Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.